US 12297509
Biomarkers for predicting tumor response to and toxicity of immunotherapy
granted A61KA61K2039/505A61K39/00
Quick answer
US patent 12297509 (Biomarkers for predicting tumor response to and toxicity of immunotherapy) held by MIRA DX, INC. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRA DX, INC.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/00, A61P, A61P35/00